Unsubscribe from this Mailing List

Unsubscribe from this Mailing List

In the early 2010s, as a hospitalist at Oregon Health & Science University (OHSU), Honora Englander, M.D., was noticing more hospitalizations related to substance use disorder (SUD) c | Amid new imple...

Unsubscribe from this Mailing List

The IMPOWR-Yale Organizations United (YOU) Center at Yale School of Medicine has developed a robust model for engaging communities of people with lived

Background Infective endocarditis (IE) related to opioid use disorder (OUD) and injection substance use is on the rise. Multidisciplinary care is recommended for individuals with substance-related I.....

In January 2026, the Pediatric and Adolescent Addiction Consult Service at Yale New Haven Children’s Hospital celebrated its five-year anniversary. Established

Federal actions and proposals have reignited debate over methadone and buprenorphine, worrying addiction experts and patient groups.

A new study published in JAMA Network Open on May 7, 2026, engaged 42 national experts in hospital-based addiction treatment in a consensus-building process to

In this 332nd episode I welcome Dr. Tom Hickey to the show to discuss Buprenorphine. We discuss it’s pharmacology, safety, use in OUD, Chronic pain, acute perioperative pain, we address some …

People who have been stable for years are suddenly re-exposed to risk — not because their disease worsened, but because their coverage did.